pyrimethamine [Antibiotic]

Download Sequences


Ontology CARD's Antibiotic Resistance Ontology
Accession ARO:3009163
DefinitionPyrimethamine is a competitive inhibitor of dihydrofolate reductase (DHFR). DHFR is a key enzyme in the redox cycle for production of tetrahydrofolate, a cofactor that is required for the synthesis of DNA and proteins. It is typically used in combination with other drugs to treat parasitic infections, including malaria and toxoplasmosis. When combined with sulfadoxine, it can be used as prophylaxis for Pneumocystis jerovecii (fungi) induced pneumonia (PCP). However, this compound is generally not recommended for PCP prophylaxis unless trimethoprim-sulfamethoxazole, pentamidine, dapsone/pyrimethamine/leucovorin, atovaquone or dapsone cannot be used.
SMILESCCC1=C(C(=NC(=N1)N)N)C2=CC=C(C=C2)Cl
PubChem4993
ChEMBLCHEMBL36
CHEBI8673
CAS58-14-0
Drug Classantibiotic without defined classification
Classification3 ontology terms | Show
Parent Term(s)1 ontology terms | Show
Sub-Term(s)
2 ontology terms | Show
Publications

EYLES DE, et al. 1955. Antibiot Chemother (Northfield) 5(10):529-39 An evaluation of the curative effects of pyrimethamine and sulfadiazine, alone and in combination, on experimental mouse toxoplasmosis. (PMID 24543765)

McFadden DC, et al. 2001. Drug Resist Updat 4(2):79-84 Resistance as a tool in the study of old and new drug targets in Toxoplasma. (PMID 11512524)

Curator Acknowledgements
Curator Description Most Recent Edit